JAMA Ophthalmology
October 17, 2024
is video
JAMA
Viewpoint
Health and the 2024 US Election
October 17, 2024
Michael A. Incze, MD, MSEd; Caty Simon; Leslie W. Suen, MD, MAS
JAMA. 2024; 10.1001/jama.2024.19914
This work discusses unfettering methadone from outdated regulations to empower patients to access treatment and advocate for methadone's expansion in their local communities by working with pharmacies and local health systems.
JAMA
Original Investigation
October 17, 2024
Bohdan Nosyk, PhD; Jeong Eun Min, MSc; Fahmida Homayra, MSc; Megan Kurz, MSc; Brenda Carolina Guerra-Alejos, MD, MPH; Ruyu Yan, BA; Micah Piske, MScPH; Shaun R. Seaman, PhD; Paxton Bach, MD, MSc; Sander Greenland, MA, MS, DrPH; Mohammad Ehsanul Karim, PhD; Uwe Siebert, MD, MPH, MSc, ScD; Julie Bruneau, MD, MSc; Paul Gustafson, PhD; Kyle Kampman, MD; P. Todd Korthuis, MD, MPH; Thomas Loughin, PhD; Lawrence C. McCandless, PhD; Robert W. Platt, PhD; Kevin T. Schnepel, PhD; M. Eugenia Socías, MD, MSc
JAMA. 2024; 10.1001/jama.2024.16954
This population-based retrospective cohort study uses linked health administrative databases to assess the risk of treatment discontinuation and mortality among adults in British Columbia, Canada, receiving buprenorphine/naloxone vs methadone for the treatment of opioid use disorder.
JAMA
Comment & Response
October 17, 2024
Gil Yosipovitch, MD; Daniel Butler, MD
JAMA. 2024; 10.1001/jama.2024.17981
JAMA
Comment & Response
October 17, 2024
Chaker Ben Salem, MD; Nadia Ghariani, MD
JAMA. 2024; 10.1001/jama.2024.17978
JAMA
Research Letter
October 17, 2024
Fergus K. O’Connor, PhD; Robert D. Meade, PhD, MPH; Katie E. Wagar, BHKRC; Roberto C. Harris-Mostert, BSc; Emily J. Tetzlaff, MHK; James J. McCormick, PhD; Glen P. Kenny, PhD
JAMA. 2024; 10.1001/jama.2024.19457
This study assessed whether electric fans limit core temperature increases in adults aged 65 to 85 years exposed to conditions similar to those experienced in homes during heat waves in North America.
JAMA Oncology
Original Investigation
October 17, 2024
Nathalie Gaspar, MD, PhD; Giun-Yi Hung, MD, PhD; Sandra J. Strauss, MBBS, PhD; Quentin Campbell-Hewson, MD; Filemon S. Dela Cruz, MD; Julia L. Glade Bender, MD; Kyung-Nam Koh, MD, PhD; Sarah B. Whittle, MD; Godfrey Chi-Fung Chan, MD; Nicolas U. Gerber, MD; Sauli Palmu, MD, PhD; Daniel A. Morgenstern, MB BChir, PhD; Alessandra Longhi, MD; Fredrik Baecklund, MD, PhD; Jun Ah Lee, MD, PhD; Franco Locatelli, MD; Catalina Márquez Vega, MD; Katherine A. Janeway, MD; Geoffrey McCowage, MD; Martin G. McCabe, MB BChir, PhD; Behzad Bidadi, MD; Jie Huang, PhD; Jodi McKenzie, PhD; Chinyere E. Okpara, PhD; Francisco Bautista, MD, PhD; OLIE Study Investigators
open access
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.4381
This randomized clinical trial evaluates whether the combination of lenvatinib plus ifosfamide and etoposide improves outcomes in children and young adults with relapsed osteosarcoma.
JAMA Oncology
Comment & Response
October 17, 2024
Omar El-Taji, MBchB, MRes; Ashwin Sachdeva, MBBS, PhD
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.4584
JAMA Oncology
Comment & Response
October 17, 2024
Manali I. Patel, MD, MPH, MS
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.4578
JAMA Oncology
Comment & Response
October 17, 2024
Yubo Tang, PhD; Qingde Wa, MD; Shuai Huang, MD
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.4581
JAMA Oncology
Comment & Response
October 17, 2024
Kai Kang, MD; Yijun Wu, MD
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.4575
JAMA Oncology
Brief Report
October 17, 2024
Zhuo Tony Su, MD; Mufaddal Mamawala, MBBS, MPH; Patricia K. Landis, BA; Claire M. de la Calle, MD; Nitin Shivappa, PhD, MBBS, MPH; Michael Wirth, PhD, MSPH; James R. Hébert, MSPH, ScD; Christian P. Pavlovich, MD; Bruce J. Trock, PhD, MPH
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.4406
This cohort study examines whether there is an association of diet quality and dietary inflammatory potential with prostate cancer grade reclassification in men with grade group 1 disease undergoing active surveillance.